North Carolina Personal Injury Lawyers: Hardison & Associates  
NORTH CAROLINA INJURY OFFICES
 

Raleigh   |  Dunn  |  Fayetteville  |  Southern Pines  |  Durham  |  Wilmington

 
1(800)-434-8399   
|    Office Details
 


Practice Areas: Injuries, Accidents, Workers Compensation
Personal Injury
Car Accidents
Truck Accidents
Motorcycle Accidents
Dog Bites
School Bus Accidents
Workers Compensation
     - Forklift Injuries
Social Security Disability
     - VA Disability Benefits
Nursing Home Negligence
Catastrophic Injuries
Mass Torts
Serzone
Stock Fraud Victims
Vioxx
Guidant Defibrillators
Bextra
Fosamax
Ortho Evra
ACE Inhibitors
Stevens-Johnson Syndrome
ReNu MoistureLoc Contact Solution
Bard Composix Kugel Large Patches
Immigration

About Our Lawyers
About Our Firm
Our Attorneys
Our Staff
How We Work
Employment Opportunities
Firm News
Newsletter

Client Rights
Bill of Rights
Client Advocate
Client Satisfaction Guarantee
 
Legal Questions & Answers
Car Accidents FAQs
Truck Accidents FAQs
Immigration FAQs
Personal Injury FAQs
Workers Compensation FAQs
Nursing Home Negligence FAQs
Catastrophic Injuries FAQs
Mass Torts FAQs
Social Security FAQs
Fosamax FAQs
Stock Fraud FAQs
ReNu MoistureLoc Contact Solution FAQs

Client Testimonials
Articles
Injury Glossary
Legal Resources: Research, Links, Lawyers
Legal Tools
North Carolina Communities: Raleigh, Wake County, Greensboro, Triangle, Durham, Charlotte, Fayetteville
Contact Our Injury Lawyers
Site Map


Legal News Feeds
NC Accident Headlines
NC Workers' Compensation News
Social Security Disability Headlines
 



VIOXX PULLED FROM MARKET

Merck & Co., the maker of the arthritis pain reliever VIOXX, has voluntarily removed the drug from the market due to new data showing it increases the risk of heart attack and strokes.

To view the current status of the litigation, see our articles, First Vioxx Trial Verdict and Cases Challenge 18-Month Damage Claim and Analysts Predict Merck’s Vioxx Liabilities Could Hit $50 Billion.

This is one of the largest-ever withdrawals of a drug, says the Food and Drug Administration's Steven Galson. Drugmaker Merck (MRK) says 84 million people worldwide have taken the heavily promoted drug, available in the USA since May 1999. About 2 million Americans are on Vioxx, Galson says. "We have been concerned and aware of the potential for cardiovascular effects for the last few years," he says. "This is not a total surprise."
 


 

NAME:


PHONE:


EMAIL:


HOW DID YOU HEAR
ABOUT US?

QUESTIONS/COMMENTS:

  In August, an FDA-funded analysis involving Kaiser Permanente patients found more heart attacks and sudden cardiac deaths among people taking Vioxx than among those on Celebrex or on conventional nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen and aspirin.

In November 2000, Merck published a study in the New England Journal of Medicine that found a higher rate of heart attacks in patients assigned Vioxx than those assigned to naproxen (an NSAID sold as Aleve). Because of that finding, the FDA in April 2002 required a new warning on the Vioxx label.

The implications of the Vioxx withdrawal for other COX-2 inhibitors aren't yet clear. Merck says new data - from a three-year study comparing Vioxx with a placebo in 2,600 patients with colon polyps - showed a higher risk of heart attack and stroke only after 18 months of use. None of the other COX-2 drugs have data for longer than a year, Galson says.

In 2000, Merck spent $160.8 million on direct to consumer Vioxx marketing. Many people are familiar with Vioxx television advertisements featuring famous figure skater Dorothy Hamill. Sid Wolfe, a physician and director of the Health Research Group of the advocacy group Public Citizen in Washington, DC said, "Dorothy Hamill doesn't tell people they have a four times higher risk of a heart attack on Vioxx."

CLICK HERE FOR A FREE CASE REVIEW

News Alert

Jurors award $47.5 million in Vioxx decision
March 13, 2007 (Associated Press) – “Merck & Co.’s painkiller Vioxx contributed to an Idaho postal worker’s heart attack, a jury in Atlantic City ruled Monday, reversing the verdict in the man’s first trial and hitting Merck with a total of $47.5 million in damages."

Forbes: June 29, 2006 - Key Vioxx 18-month Usage Claim Withdrawn by Jounal, Dealing Significant Potential Blow To Merck

Reuters, April 5, 2006 - Merck Loses Second Vioxx Case; Jury awards $4.5 million in Vioxx verdict against Merck

Merck may settle some Vioxx cases, NJ trial looms
August 26, 2005 - Reuters - Merck & Co Inc. on Friday signaled it may consider settling some lawsuits alleging harm from its Vioxx pain drug, as it gears up for its second Vioxx court battle -- this time in its own backyard.

Merck Found Liable For Man's Death In Vioxx Trial
08-19-05 - Bloomberg -Merck & Co. must pay more than $253 million to the family of a Texas man who died after taking the company's Vioxx painkiller.

>
FDA Drug Safety Report


Legal Links   Legal Resources   North Carolina Lawyers   Personal Injury Lawyers
© - Hardison & Associates / ASK LAWYER NC. Attorneys at Law, Raleigh, NC.  - All rights reserved.
North Carolina Personal Injury Law Firm representing Car Accidents, Truck Accidents, Motorcycle Wrecks, Workers Compensation, Social Security Disability Claims,
Nursing Home Abuse & Negligence, Catastrophic, Car, Truck & Other Vehicular Accidents / Injuries, Collisions, Crashes, Dog Bites, Animal Attacks
Including Mass Torts such as Vioxx, Stock & Securities Fraud, and Broker Misconduct - Serving Raleigh, Dunn, Durham, Charlotte,
Greensboro, High Point, Southern Pines, Fayetteville and surrounding Wake County, Orange, Johnston,
Chatham, Harnett, Nash, Franklin, Cumberland, NC Counties - Site by Consultwebs.com: Law Firm Website Designers / Personal Injury Lawyer Marketing